Relevance of quality of life assessment to the evaluation of combined‐modality therapy

Charles L. Shapiro

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Quality of life (QOL) assessment is a research tool which is incorporated into clinical trials to provide information about the ways in which the treatment affects the individuals sense of well‐being and his physical, psychologic, and social functions. In the appropriate setting QOL assessment offers additional endpoints, beyond the traditional response rates and survival durations, to evaluate cancer treatments in ways which can be particularly meaningful to patients. Selected aspects of QOL methodology and the application of QOL assessment to the evaluation of combined‐modality therapies for gastrointestinal cancers are discussed.

Original languageEnglish
Pages (from-to)65-69
Number of pages5
JournalSeminars in Surgical Oncology
Volume9
Issue number1
DOIs
StatePublished - 1993
Externally publishedYes

Keywords

  • QOL
  • cancer treatments
  • gastrointestinal cancers

Fingerprint

Dive into the research topics of 'Relevance of quality of life assessment to the evaluation of combined‐modality therapy'. Together they form a unique fingerprint.

Cite this